MedTrace Logo

Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term

NCT00936637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2009-07-10

No results posted yet for this study

Summary

The purpose of this study is to assess growth in infants who are fed an extensively hydrolyzed formula.

Conditions

  • Growth

Interventions

OTHER

Extensively hydrolyzed infant formula

Sponsors & Collaborators

  • Perrigo Nutritionals

    lead INDUSTRY

Principal Investigators

  • Cynthia M Barber, PhD · Perrigo Nutritionals

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Day
Max Age
21 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00936637 on ClinicalTrials.gov